BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15981122)

  • 1. Venous angiomata: treatment with sclerosant foam.
    Pascarella L; Bergan JJ; Yamada C; Mekenas L
    Ann Vasc Surg; 2005 Jul; 19(4):457-64. PubMed ID: 15981122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous disorders: treatment with sclerosant foam.
    Bergan J; Pascarella L; Mekenas L
    J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foam sclerotherapy of venous malformations.
    Bergan J; Cheng V
    Phlebology; 2007; 22(6):299-302. PubMed ID: 18274339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of microfoam sclerotherapy in a patient with Klippel-Trenaunay syndrome and a patent foramen ovale.
    Redondo P; Bastarrika G; Sierra A; Martínez-Cuesta A; Cabrera J
    Arch Dermatol; 2009 Oct; 145(10):1147-51. PubMed ID: 19841402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of venous malformations with sclerosant in microfoam form.
    Cabrera J; Cabrera J; Garcia-Olmedo MA; Redondo P
    Arch Dermatol; 2003 Nov; 139(11):1409-16. PubMed ID: 14623700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Color duplex-guided sclerotherapy for the treatment of venous malformations.
    Yamaki T; Nozaki M; Sasaki K
    Dermatol Surg; 2000 Apr; 26(4):323-8. PubMed ID: 10759818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe chronic venous insufficiency treated by foamed sclerosant.
    Pascarella L; Bergan JJ; Mekenas LV
    Ann Vasc Surg; 2006 Jan; 20(1):83-91. PubMed ID: 16378144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-guided foam sclerotherapy in patients with Klippel-Trenaunay syndrome.
    Nitecki S; Bass A
    Isr Med Assoc J; 2007 Feb; 9(2):72-5. PubMed ID: 17348474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial.
    Alòs J; Carreño P; López JA; Estadella B; Serra-Prat M; Marinel-Lo J
    Eur J Vasc Endovasc Surg; 2006 Jan; 31(1):101-7. PubMed ID: 16226901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular radiofrequency ablation: a novel treatment of venous insufficiency in Klippel-Trenaunay patients.
    Frasier K; Giangola G; Rosen R; Ginat DT
    J Vasc Surg; 2008 Jun; 47(6):1339-45. PubMed ID: 18514850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovenous radiofrequency ablation and combined foam sclerotherapy treatment of multiple refluxing perforator veins in a Klippel-Trenaunay syndrome patient.
    Harrison C; Holdstock J; Price B; Whiteley M
    Phlebology; 2014 Dec; 29(10):698-700. PubMed ID: 23868201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
    Ukritmanoroat T
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic impairment, venous segmental disease, and clinical severity scoring in limbs with Klippel-Trenaunay syndrome.
    Delis KT; Gloviczki P; Wennberg PW; Rooke TW; Driscoll DJ
    J Vasc Surg; 2007 Mar; 45(3):561-7. PubMed ID: 17275246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foam sclerotherapy: techniques and uses.
    Bunke N; Brown K; Bergan J
    Perspect Vasc Surg Endovasc Ther; 2009 Jun; 21(2):91-3. PubMed ID: 19767405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.
    Blaise S; Charavin-Cocuzza M; Riom H; Brix M; Seinturier C; Diamand JM; Gachet G; Carpentier PH
    Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):412-7. PubMed ID: 21111641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.